Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 73,849 | 62,436 | 47,051 | 39,285 | 25,998 |
| Marketable Securities | 21 | 28,764 | 62,976 | 87,065 | 115,822 |
| TOTAL | $80,661 | $93,580 | $111,886 | $129,207 | $144,768 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 799 | 5,010 | 5,295 | 4,022 | 2,707 |
| TOTAL | $799 | $5,010 | $5,295 | $4,022 | $2,707 |
| Total Assets | $81,460 | $98,590 | $117,181 | $133,229 | $147,475 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,086 | 4,493 | 2,072 | 4,444 | 5,056 |
| Accrued Expenses | 3,900 | 6,775 | 8,035 | 5,863 | 4,837 |
| TOTAL | $6,387 | $11,604 | $10,548 | $10,736 | $10,310 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 276 | 0 | 0 | 116 | 240 |
| TOTAL | $276 | $N/A | $N/A | $116 | $240 |
| Total Liabilities | $6,663 | $11,604 | $10,548 | $10,852 | $10,550 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,885 | 21,816 | 21,816 | 21,773 | 21,697 |
| Retained earnings | -151,893 | -137,506 | -115,918 | -98,320 | -82,004 |
| Other shareholders' equity | 0 | 14 | 81 | 82 | -3 |
| TOTAL | $74,797 | $86,986 | $106,633 | $122,377 | $136,925 |
| Total Liabilities And Equity | $81,460 | $98,590 | $117,181 | $133,229 | $147,475 |